THE ALIGN-AS EFS TRIAL: JenaValve Pericardial TAVR Aortic Stenosis Study
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
Summary
- Conditions
- Aortic Valve Stenosis
- Cardiovascular Diseases
- Heart Diseases
- Heart Valve Diseases
- Ventricular Outflow Obstruction
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
This study will examine the use of a TAVR (Transcatheter Aortic Valve Replacement), which is a minimally invasive procedure designed to replace the aortic valve inside the heart. This less invasive surgical approach called TAVR is offered to those patients who are high risk for undergoing open heart...
This study will examine the use of a TAVR (Transcatheter Aortic Valve Replacement), which is a minimally invasive procedure designed to replace the aortic valve inside the heart. This less invasive surgical approach called TAVR is offered to those patients who are high risk for undergoing open heart surgery to replace the aortic valve. In this study, TAVR will be performed using the JenaValve Pericardial TAVR System.
Tracking Information
- NCT #
- NCT02732691
- Collaborators
- Not Provided
- Investigators
- Study Chair: Martin B Leon, MD New York-Presbyterian Hospital/Columbia University Medical Center, USA Principal Investigator: Torsten Vahl, MD New York-Presbyterian Hospital/Columbia University Medical Center, USA Principal Investigator: Vinod Thourani, MD Emory University School of Medicine, USA Principal Investigator: Hendrik Treede, MD University Hospital Bonn, Germany
Get Well Soon